Uses

Used as part of chemotherapy regimens, particularly as adjuvant treatment for certain breast cancers.

Do not use if

Contraindicated in severe cardiac disease, severe hepatic impairment, severe myelosuppression, and prior excessive anthracycline exposure.

May cause myelosuppression, nausea, hair loss, cardiotoxicity, mucositis, and tissue injury if extravasation occurs.

Serious cardiac toxicity, secondary malignancies, severe myelosuppression, and tissue necrosis can occur.

Epirubicin is an anthracycline that intercalates into DNA and inhibits topoisomerase II, impairing cancer cell replication.

Refrigerate at 2–8°C and protect from light. Do not freeze.